STAT3 is a known breast oncogene [140–142] that may bestow a direct survival advantage on breast cancer cells in addition to modulating the tumour microenvironment to facilitate neoplastic cell survival and/or infiltration and invasion. Here, STAT3 is linked to breast carcinoma.